Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
81
days
Long-Term Efficacy of Adjunctive Cenobamate by Focal Seizure Subtypes: Open-Label Extension of a Randomized Clinical Study in a Multinational Asian Population
Authors
Peimin Yu; Xintong Wu; Ling Chen; Eunyeong Choe; Louis Ferrari; Kyoung Heo; Seung Bong Hong; Koji Iida; Yong Heui Jeon; Jiwon Jung; Marc Kamin; Kensuke Kawai; Ji Hyun Kim; Myung Won Kim; Sang Kun Lee; Jungshin Park; William E. Rosenfeld; Tiancheng Wang; Takamichi Yamamoto; Sunita N. MisraShow moreShow less
Affiliations
1. Huashan Hospital, Fudan University, Shanghai, China; 2. West China Hospital, Sichuan University, Chengdu, China; 3. First Affiliated Hospital of Kunming Medical University, Kunming, China; 4. SK Biopharmaceuticals Co., Ltd., Seongnam, Republic of Korea; 5. Fifth Floor, SK Life Science, Inc., Paramus, USA; 6. Yonsei University College of Medicine, Seoul, Republic of Korea; 7. Epilepsy and Sleep Center, St. Peter’s General Hospital, Seoul, Republic of Korea; 8. Hiroshima University Hospital, Hiroshima, Japan; 9. Jichi Medical University, Shimotsuke, Japan; 10. Korea University Guro Hospital, Seoul, Republic of Korea; 11. Seoul National University College of Medicine, Seoul, Republic of Korea; 12. Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, USA; 13. Lanzhou University Second Hospital, Lanzhou, China; 14. Seirei Mikatahara General Hospital, Hamamatsu, JapanShow moreShow less
43
days
The Global Burden of Migraine: A Narrative Review and Expert Perspective on Disease Burden, Unmet Needs, and Policy Priorities
Authors
João Victor Rocha; Cristina Tassorelli; Debashish Chowdhury; Elena Ruiz de la Torre; Elizabeth Leroux; Mauro Eduardo Jurno; Rob Music; Taoufik Alsaadi; Teresa MarinettiShow moreShow less
Affiliations
1. Policy Wisdom LLC, Puerto Rico, USA; 2. Department of Brain and Behavioral Sciences at the University of Pavia, Pavia, Italy; 3. IRCCS C. Mondino Foundation, Pavia, Italy; 4. Center for Neurosciences, BLK-MAX Super Speciality Hospital, New Delhi, India; 5. European Migraine and Headache Alliance, Brussels, Belgium; 6. Brunswick Medical Center Glen Neuro, Montreal, Canada; 7. McGill’s Neurology Department, Montreal, Canada; 8. Medicine School of Barbacena, Barbacena, Brazil; 9. Brazilian Headache Society, Ribeirão Preto, Brazil; 10. The Migraine Trust, London, UK; 11. Neurology Department at the American Center of Psychiatry and Neurology, Abu Dhabi, United Arab EmiratesShow moreShow less
62
days
Patient Preferences for Self-Administered Subcutaneous Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy
Authors
Batyrkhan Kuatov; Sarah-Jane Cashmore; Noemi Hahn; Julia Braverman; Laurence Undreiner; Shicheng Weng; Ben GibbonsShow moreShow less
Affiliations
1. CSL Behring, Bern, Switzerland; 2. Bryter Inc., New York, USA; 3. CSL Behring, Waltham, USA; 4. CSL Behring, Paris, FranceShow moreShow less
40
days
Concepts and Assessment of Fatigue in Myasthenia Gravis: A Scoping Review
Authors
Sarah Hoffmann; Nishtha Chandra; Channa Hewamadduma; Lorenzo Maggi; Michael D. Weiss; Jos Bloemers; Veronica Porkess; Thaïs Tarancón; Henry J. Kaminski; John VissingShow moreShow less
Affiliations
1. Charité–University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Clinic for Neurology, Neuroscience Clinical Research Center (NCRC), Berlin, Germany; 2. Ogilvy Health, Manchester, UK; 3. NIHR BRC Neuroscience Centre, Academic Neuromuscular Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; 4. Sheffield Institute for Translational Neuroscience (SITraN), School of Medicine and Population Health, University of Sheffield, Sheffield, UK; 5. Neuroimmunology and Neuromuscular Diseases Unit Foundation IRCCS, Neurological Institute Carlo Besta, Milan, Italy; 6. Department of Neurology, University of Washington Medical Center, Seattle, USA; 7. UCB, Breda, The Netherlands; 8. UCB, Slough, UK; 9. UCB, Madrid, Spain; 10. Department of Neurology and Rehabilitation Medicine, George Washington University, Washington, USA; 11. Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkShow moreShow less
89
days
After the Spasms: Long-Term Outcomes Following Pulsatile Dexamethasone Therapy for Infantile Epileptic Spasms Syndrome: A Retrospective Observational Study
Authors
Kabak Ekaterina; Isabella Claudia Leitner; Stark Birgit; Gröppel GudrunShow moreShow less
Affiliations
1. Department of Pediatrics and Adolescent Medicine, Johannes Kepler University Linz, Linz, Austria; 2. Clinical Research Institute for Neurosciences, Johannes Kepler University Linz and Kepler University Hospital, Linz, AustriaShow moreShow less
119
days
Three-Year Follow-Up of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Long-Term Phase 3 EMBARK Trial Results
Authors
Jerry R. Mendell; Francesco Muntoni; Craig M. McDonald; Eugenio M. Mercuri; Nicolas Deconinck; Emma Ciafaloni; Hirofumi Komaki; Carmen Leon-Astudillo; Andrés Nascimento; Crystal Proud; Ulrike Schara-Schmidt; Aravindhan Veerapandiyan; Craig M. Zaidman; Matthew Furgerson; Damon R. Asher; Mark Vivien; Yi Sun; Alexander P. Murphy; Pooneh Pordeli; Carmen O. Torre; Marianna Manfrini; Marianne Gerber; Louise R. Rodino-KlapacShow moreShow less
Affiliations
1. Sarepta Therapeutics, Inc., Cambridge, USA; 2. Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health and Institute of Neurology, University College London, & Great Ormond Street Hospital Trust, London, UK; 3. UC Davis Health, Sacramento, USA; 4. Pediatric Neurology Institute, Catholic University and Nemo Pediatrico, Fondazione Policlinico Gemelli IRCCS, Rome, Italy; 5. Hôpital Universitaire Des Enfants Reine Fabiola ULB, Brussels, Belgium; 6. University of Rochester Medical Center, Rochester, USA; 7. Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan; 8. Department of Pediatrics, University of Florida, Gainesville, USA; 9. Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Fundacion Sant Joan de Déu, CIBERER – ISC III, Barcelona, Spain; 10. Children’s Hospital of the King’s Daughters, Norfolk, USA; 11. Department of Pediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, University Clinic Essen, University of Duisburg-Essen, Essen, Germany; 12. Department of Pediatrics, Division of Neurology, University of Arkansas for Medical Sciences, Arkansas Children’s Hospital, Little Rock, USA; 13. Department of Neurology, Washington University in St Louis, St Louis, USA; 14. Roche Products Ltd, Welwyn Garden City, UK; 15. Hoffmann–La Roche, Mississauga, Canada; 16. F. Hoffmann-La Roche Ltd, Basel, SwitzerlandShow moreShow less
FAQ
How long does Neurology and Therapy take to review a manuscript?
As of 2026-11-18, CrushSCI has 19 complete review records for Neurology and Therapy. The fastest paper went from submission to acceptance in 22 days (Current and Emerging Therapies for Generalized Myasthenia Gravis: Toward Precision Medicine, received 2026-09-09, accepted 2026-10-01); the slowest took 119 days. The average is 66.8 days and the median is 62 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
